HAS2 and breast cancer: Carmen et al. demonstrated that HAS2 is a VD repressed gene, showing that VD not only inhibited the expression of HAS2 and HA synthesis, but also caused downregulation of BC stem cell marker CD44, which acts as HA receptor in Hs578T cells [167].